Search Results - "Comer, Frank"

Refine Results
  1. 1

    HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells by Xia, Leiming, Wen, Lu, Qin, You, Dobson, Hannah E, Zhang, Tao, Comer, Frank I, Hinrichs, Mary Jane, Oberst, Michael D, Coats, Steven R, Chang, Alfred E, Liu, Yuanyuan, Bao, Yangyi, Dai, Fu, Wicha, Max S, Li, Qiao

    Published in Cell chemical biology (20-05-2021)
    “…We previously tested HER2-targeted antibody-drug conjugates (ADCs) in immunocompromised (SCID) mice, precluding evaluation of host immunity, impact on cancer…”
    Get more information
    Journal Article
  2. 2

    TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium by Lee, Susan, Comer, Frank I, Sasaki, Atsuo, McLeod, Ian X, Duong, Yung, Okumura, Koichi, Yates, 3rd, John R, Parent, Carole A, Firtel, Richard A

    Published in Molecular biology of the cell (01-10-2005)
    “…Dictyostelium cells form a multicellular organism through the aggregation of independent cells. This process requires both chemotaxis and signal relay in which…”
    Get full text
    Journal Article
  3. 3

    Reciprocity between O-GlcNAc and O-Phosphate on the Carboxyl Terminal Domain of RNA Polymerase II by Comer, Frank I, Hart, Gerald W

    Published in Biochemistry (Easton) (03-07-2001)
    “…The carboxyl terminal domain of RNA polymerase II has multiple essential roles in transcription initiation, promoter clearance, transcript elongation, and the…”
    Get full text
    Journal Article
  4. 4

    Phosphoinositides Specify Polarity during Epithelial Organ Development by Comer, Frank I., Parent, Carole A.

    Published in Cell (26-01-2007)
    “…The molecular mechanisms that integrate cellular polarity with tissue architecture during epithelial morphogenesis are poorly understood. Using a…”
    Get full text
    Journal Article
  5. 5

    PI 3-Kinases and PTEN: How Opposites Chemoattract by Comer, Frank I., Parent, Carole A.

    Published in Cell (31-05-2002)
    “…Phosphatidylinositol lipids, such as PI(4,5)P 2 and PI(3,4,5)P 3, are key mediators in diverse intracellular signaling pathways. Two recent reports examine how…”
    Get full text
    Book Review Journal Article
  6. 6

    O-GlcNAc Transferase Is in a Functional Complex with Protein Phosphatase 1 Catalytic Subunits by Wells, Lance, Kreppel, Lisa K., Comer, Frank I., Wadzinski, Brian E., Hart, Gerald W.

    Published in The Journal of biological chemistry (10-09-2004)
    “…A hallmark of signal transduction is the dynamic and inducible post-translational modification of proteins. In addition to the well characterized…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Phosphoinositide 3-kinase activity controls the chemoattractant-mediated activation and adaptation of adenylyl cyclase by Comer, Frank I, Parent, Carole A

    Published in Molecular biology of the cell (01-01-2006)
    “…The binding of chemoattractants to cognate G protein-coupled receptors activates a variety of signaling cascades that provide spatial and temporal cues…”
    Get full text
    Journal Article
  9. 9

    O-GlcNAc and the control of gene expression by Comer, Frank I, Hart, Gerald W

    Published in BBA - General Subjects (06-12-1999)
    “…Many eukaryotic proteins contain O-linked N-acetylglucosamine (O-GlcNAc) on their serine and threonine side chain hydroxyls. In contrast to classical cell…”
    Get full text
    Book Review Journal Article
  10. 10

    The PI3K-Mediated Activation of CRAC Independently Regulates Adenylyl Cyclase Activation and Chemotaxis by Comer, Frank I., Lippincott, Christopher K., Masbad, Joseph J., Parent, Carole A.

    Published in Current biology (26-01-2005)
    “…The ability of a cell to detect an external chemical signal and initiate a program of directed migration along a gradient comprises the fundamental process…”
    Get full text
    Journal Article
  11. 11

    Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex by Akimoto, Yoshihiro, Comer, Frank I, Cole, Robert N, Kudo, Akihiko, Kawakami, Hayato, Hirano, Hiroshi, Hart, Gerald W

    Published in Brain research (21-03-2003)
    “…O-linked N-acetylglucosamine (O-GlcNAc) is a ubiquitous nucleocytoplasmic protein modification that has a complex interplay with phosphorylation on…”
    Get full text
    Journal Article
  12. 12

    Characterization of a Mouse Monoclonal Antibody Specific for O-Linked N-Acetylglucosamine by Comer, Frank I., Vosseller, Keith, Wells, Lance, Accavitti, Mary Ann, Hart, Gerald W.

    Published in Analytical biochemistry (15-06-2001)
    “…β-O-linked N-acetylglucosamine (O-GlcNAc) is an abundant posttranslational modification of resident nuclear and cytoplasmic proteins in eukaryotes. Increasing…”
    Get full text
    Journal Article
  13. 13

    Site-Specific GlcNAcylation of Human Erythrocyte Proteins by Wang, Zihao, Park, Kyoungsook, Comer, Frank, Hsieh-Wilson, Linda C., Saudek, Christopher D., Hart, Gerald W.

    Published in Diabetes (New York, N.Y.) (01-02-2009)
    “…Site-Specific GlcNAcylation of Human Erythrocyte Proteins Potential Biomarker(s) for Diabetes Zihao Wang 1 , Kyoungsook Park 1 , Frank Comer 1 , Linda C…”
    Get full text
    Journal Article
  14. 14

    Proton Transfer in the Mechanism of Triosephosphate Isomerase by Harris, Thomas K, Cole, Robert N, Comer, Frank I, Mildvan, Albert S

    Published in Biochemistry (Easton) (24-11-1998)
    “…Triosephosphate isomerase (TIM) catalyzes the reversible interconversion of dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (GAP), with…”
    Get full text
    Journal Article
  15. 15

    Abstract 514: Specific anti-HER2 host immunity conferred by HER2-targeted antibody drug conjugate therapy and checkpoint blockade by Qin, You, Dobson, Hannah E., Comer, Frank I., Chang, Alfred E., Wicha, Max S., Li, Qiao

    Published in Cancer research (Chicago, Ill.) (01-07-2021)
    “…Using HER2-targeted antibody drug conjugates (ADC), we tested the therapeutic efficacy, direct impact on cancer stem cells (CSCs), and potential added benefit…”
    Get full text
    Journal Article
  16. 16

    Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody by Oganesyan, Vaheh, Peng, Li, Bee, Jared S., Li, John, Perry, Samuel R., Comer, Frank, Xu, Linda, Cook, Kimberly, Senthil, Kannaki, Clarke, Lori, Rosenthal, Kim, Gao, Changshou, Damschroder, Melissa, Wu, Herren, Dall’Acqua, William

    Published in The Journal of biological chemistry (01-06-2018)
    “…Pathways of human epidermal growth factor (EGF) receptors are activated upon ligand-dependent or -independent homo- or heterodimerization and their subsequent…”
    Get full text
    Journal Article
  17. 17

    Site-Specific GlcNAcylation of Human Erythrocyte Proteins Potential Biomarker(s) for Diabetes by ZIHAO WANG, PARK, Kyoungsook, COMER, Frank, HSIEH-WILSON, Linda C, SAUDEK, Christopher D, HART, Gerald W

    Published in Diabetes (New York, N.Y.) (01-02-2009)
    “…O-linked N-acetylglucosamine (O-GlcNAc) is upregulated in diabetic tissues and plays a role in insulin resistance and glucose toxicity. Here, we investigated…”
    Get full text
    Journal Article
  18. 18

    Abstract LB-297: HER2-targeted antibody drug conjugates induce host immunity and target cancer stem cells and the efficacy can be enhanced by anti-PD-L1 by Xia, Leiming, Wen, Lu, Lin, Ming, Frank, Comer, Jane, Hinrichs Mary, Michael, Oberst, Steven, Coats, Bao, Yangyi, Chang, Alfred E., Wicha, Max, Li, Qiao

    Published in Cancer research (Chicago, Ill.) (01-07-2018)
    “…HER2 represents an ideal target for cancer immunotherapy. HER2-targeted antibody drug conjugate (ADC) was tested in immunocompromised (SCID) host, which…”
    Get full text
    Journal Article
  19. 19

    Abstract 4981: HER2-targeted antibody drug conjugates (ADCs) induce host immunity against cancer stem cells and are enhanced by anti-PD-L1 by Xia, Leiming, Wen, Lu, Wu, Gang, Zhang, Tao, Comer, Frank, Hinrichs, Mary Jane Masson, Oberst, Michael, Coats, Steven R., Chang, Alfred E., Liu, Yuanyuan, Bao, Yangyi, Wicha, Max, Li, Qiao

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…HER2-targeted antibody drug conjugate (ADC) was only tested in immunocompromised (SCID) host, which doesn’t allow the evaluation of the ADC-induced host immune…”
    Get full text
    Journal Article
  20. 20